Consequently, the up-regulation of the proapoptotic factor ATF4 under the PERK-axis of the UPR, upon blocking ERAD [51], provided a close link between the UPR and cancer progression but not a definitive rationale for the increase in LDs that correlate with UPR activation. This evidence concerns the gene EIF2AK3 and cancer.